Valuation: CVRx, Inc.

Market Cap 146M 128M 117M 109M 207M 13.89B 211M 1.41B 546M 6.81B 548M 536M 23.48B P/E 2026 *
-2.8x
P/E 2027 * -2.9x
Enterprise Value 171M 150M 138M 128M 243M 16.32B 247M 1.66B 642M 8.01B 644M 630M 27.59B EV / Sales 2026 *
2.63x
EV / Sales 2027 * 2.81x
Free-Float
85.82%
Yield 2026 *
-
Yield 2027 * -
1 day+1.64%
1 week+6.29%
Current month+8.56%
1 month+2.76%
3 months-38.07%
6 months-21.41%
Current year-21.41%
1 week 5.02
Extreme 5.025
6.01
1 month 4.76
Extreme 4.76
6.01
Current year 4.37
Extreme 4.3701
9.84
1 year 4.37
Extreme 4.3701
11.3
3 years 4.3
Extreme 4.2993
33.14
5 years 4.3
Extreme 4.2993
33.14
10 years 4.3
Extreme 4.2993
33.14
Manager TitleAgeSince
Chief Executive Officer 60 11/02/2024
Director of Finance/CFO 43 30/09/2020
Chief Operating Officer 57 10/08/2025
Director TitleAgeSince
Director/Board Member 61 30/09/2008
Director/Board Member 57 30/06/2020
Director/Board Member 52 30/06/2020
Date Insider Type Main position Quantity % Market Cap.
05-31
Treo Ventures LLC
OtherCompany 0 0%
05-31Free

Director

65,257 0.2459%
05-31Free

Director

19,902 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
+1.64%+6.29%-13.62%-63.77% 146M
+0.76%+0.42%+27.63%-5.91% 12.45B
+1.26%+5.26%+67.78%+34.51% 6.1B
+0.99%+2.48%+5.21%+10.20% 5.68B
+2.70%+9.77% - - 4.27B
+2.43%+3.44%-35.97%+9.68% 3.95B
+0.38%+2.39%-26.71%-27.26% 3.83B
+2.94%+1.94%+45.22%+236.71% 1.79B
+7.07%+11.86%-5.84%-60.25% 1.83B
+0.95%+0.74%+57.51%-6.38% 1.51B
Average +2.11%+3.67%+13.47%+14.17% 4.15B
Weighted average by Cap. +1.57%+3.01%+18.70%+11.34%

Financials

2026 *2027 *
Net sales 65.28M 57.05M 52.38M 48.85M 92.61M 6.22B 94.17M 631M 244M 3.05B 245M 240M 10.5B 76.18M 66.56M 61.12M 57M 108M 7.25B 110M 736M 285M 3.56B 286M 280M 12.26B
Net income -52.82M -46.15M -42.38M -39.52M -74.93M -5.03B -76.19M -510M -198M -2.47B -198M -194M -8.5B -52.14M -45.56M -41.84M -39.02M -73.96M -4.96B -75.21M -504M -195M -2.43B -196M -192M -8.39B
Net Debt 25.51M 22.29M 20.47M 19.09M 36.19M 2.43B 36.8M 246M 95.52M 1.19B 95.79M 93.71M 4.1B 68.44M 59.8M 54.91M 51.21M 97.08M 6.52B 98.72M 661M 256M 3.2B 257M 251M 11.01B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
02/07/26 US$5.580 +1.45% 71,365
01/07/26 US$5.500 +7.00% 332,198
30/06/26 US$5.140 -13.47% 414,999
29/06/26 US$5.940 +1.37% 343,571
26/06/26 US$5.860 +11.62% 791,353
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
5.500USD
Average target price
11.17USD
Spread / Average Target
+103.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock